ClinicalTrials.Veeva

Menu

Safety and Performance of the SinuSys Dilation System for Dilation of the Maxillary Sinus Ostium

S

SinuSys

Status and phase

Completed
Phase 1

Conditions

Sinusitis

Treatments

Device: SinuSys Dilation System

Study type

Interventional

Funder types

Industry

Identifiers

NCT01623050
SNS-005

Details and patient eligibility

About

The purpose of this study is to assess safety and performance of the SinuSys Dilation System for dilation of the maxillary sinus ostium.

Full description

A multicenter, single-arm, prospective study conducted to assess the safety and effectiveness of a new osmotically-driven, low-pressure expansion device for dilation of maxillary sinus ostia in patients with (CRS) Chronic Rhinosinusitis

Enrollment

36 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

-Diagnosis of chronic maxillary sinusitis

Exclusion criteria

  • Previous antrostomy
  • Sinonasal tumours
  • Cystic fibrosis
  • History of facial trauma that distorts sinus anatomy and precludes access to the maxillary sinus
  • Pregnant or breastfeeding females
  • Currently participating in another drug or device study

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

36 participants in 1 patient group

SinuSys Dilation System
Experimental group
Description:
Maxillary Sinus Dilation
Treatment:
Device: SinuSys Dilation System

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems